Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations-A population-based cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 14 12 2021
accepted: 14 02 2022
entrez: 16 3 2022
pubmed: 17 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

Isolation is an indispensable measure to contain the SARS-CoV-2 virus, but it may have a negative impact on mental health and overall wellbeing. Evidence on the isolation experience, facilitating and complicating factors is needed to mitigate negative effects. This observational, population-based cohort study enrolled 1547 adults from the general population with SARS-CoV-2 infection reported to authorities between 27 February 2020 and 19 January 2021 in Zurich, Switzerland. We assessed the proportion of individuals reporting symptoms of depression and anxiety before, during and after isolation (by DASS-21), and queried worries, positive experiences, and difficulties. We analyzed the association of these outcomes with socio-demographics using ordinal regression. Additionally, we report free-text statements by participants to capture most important aspects of isolation. The proportion of participants affected by depression or anxiety increased during isolation from 10·0% to 17·1% and 9·1% to 17·6%, respectively. Ordinal regression showed that taking care of children increased the difficulty of isolation (OR 2·10, CI 1·43-3·08) and risk of non-compliance (OR 1·63, CI 1·05-2·53), especially in younger participants. A facilitating factor that individuals commonly expressed was receiving more support during isolation. Isolation due to SARS-CoV-2 presents a mental burden, especially for younger individuals and those taking care of children. Public health authorities need to train personnel and draw from community-based resources to provide targeted support, information, and guidance to individuals during isolation. Such efforts could alleviate the negative impact isolation has on the mental and physical health of individuals and ensure compliance of the population with recommendations.

Sections du résumé

BACKGROUND
Isolation is an indispensable measure to contain the SARS-CoV-2 virus, but it may have a negative impact on mental health and overall wellbeing. Evidence on the isolation experience, facilitating and complicating factors is needed to mitigate negative effects.
METHODS AND FINDINGS
This observational, population-based cohort study enrolled 1547 adults from the general population with SARS-CoV-2 infection reported to authorities between 27 February 2020 and 19 January 2021 in Zurich, Switzerland. We assessed the proportion of individuals reporting symptoms of depression and anxiety before, during and after isolation (by DASS-21), and queried worries, positive experiences, and difficulties. We analyzed the association of these outcomes with socio-demographics using ordinal regression. Additionally, we report free-text statements by participants to capture most important aspects of isolation. The proportion of participants affected by depression or anxiety increased during isolation from 10·0% to 17·1% and 9·1% to 17·6%, respectively. Ordinal regression showed that taking care of children increased the difficulty of isolation (OR 2·10, CI 1·43-3·08) and risk of non-compliance (OR 1·63, CI 1·05-2·53), especially in younger participants. A facilitating factor that individuals commonly expressed was receiving more support during isolation.
CONCLUSION
Isolation due to SARS-CoV-2 presents a mental burden, especially for younger individuals and those taking care of children. Public health authorities need to train personnel and draw from community-based resources to provide targeted support, information, and guidance to individuals during isolation. Such efforts could alleviate the negative impact isolation has on the mental and physical health of individuals and ensure compliance of the population with recommendations.

Identifiants

pubmed: 35294465
doi: 10.1371/journal.pone.0264655
pii: PONE-D-21-39431
pmc: PMC8926272
doi:

Types de publication

Clinical Trial Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0264655

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Prehosp Disaster Med. 2021 Oct;36(5):593-598
pubmed: 34311800
Psychiatry Res. 2021 Jan;295:113631
pubmed: 33310417
Mol Psychiatry. 2021 Sep;26(9):4813-4822
pubmed: 33483692
Epidemiol Health. 2016 Nov 5;38:e2016048
pubmed: 28196409
Disaster Med Public Health Prep. 2015 Oct;9(5):547-53
pubmed: 25797363
PLoS One. 2021 Jul 12;16(7):e0254523
pubmed: 34252157
Int J Biol Sci. 2020 Mar 15;16(10):1732-1738
pubmed: 32226291
Sleep Med. 2020 Nov;75:12-20
pubmed: 32853913
Epidemiol Health. 2020;42:e2020038
pubmed: 32512661
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
BMC Public Health. 2020 Nov 27;20(1):1809
pubmed: 33246432
Med Sci Monit. 2020 Apr 26;26:e924609
pubmed: 32335579
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
PLoS One. 2020 Nov 5;15(11):e0240204
pubmed: 33152030
Am Psychol. 2020 Jul-Aug;75(5):607-617
pubmed: 32673008
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):223-234
pubmed: 33025099
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Korean Med Sci. 2021 Jan 18;36(3):e33
pubmed: 33463098
Psychiatry Res. 2020 Nov;293:113462
pubmed: 32987222
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392

Auteurs

Anja Domenghino (A)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.
Department of Visceral and Transplantation Surgery, University Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland.

Hélène E Aschmann (HE)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.
Department of Epidemiology and Biostatistics, University of California San Francisco (UCSF), San Francisco, California, United States of America.

Tala Ballouz (T)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Dominik Menges (D)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Dominique Strebel (D)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Sandra Derfler (S)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Jan S Fehr (JS)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Milo A Puhan (MA)

Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH